What is Protalus?
Protalus specializes in the design and development of advanced footwear and insoles engineered to optimize body alignment, comfort, and support. Leveraging a patented technology, their products are crafted to promote optimal posture and alleviate common issues such as plantar fasciitis and joint pain. The company's innovative insoles are designed to dynamically correct misalignment during movement, offering a solution for individuals in professions requiring long hours on their feet, like nursing, as well as for athletes and everyday users seeking enhanced comfort and support. Protalus stands behind its products with a satisfaction guarantee, aiming to restore natural movement and provide significant relief.
How much funding has Protalus raised?
Protalus has raised a total of $982K across 2 funding rounds:
Debt
$350K
Debt
$632K
Debt (2020): $350K with participation from PPP
Debt (2021): $632K led by PPP
Key Investors in Protalus
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Protalus?
The recent major strategic investment signals a pivotal growth phase for Protalus, likely enabling the company to scale its operations, expand its product line, and enhance its market reach. This infusion of capital is expected to fuel further innovation in biomechanical footwear solutions and solidify its position as a leader in supportive insole technology. Protalus is poised to capitalize on this momentum to address a broader consumer base seeking ergonomic and therapeutic footwear options.
See full Protalus company page
